PIN31 BUDGET-IMPACT ANALYSIS OF IBALIZUMAB IN THE TREATMENT OF US MEDICARE BENEFICIARIES WITH MULTIDRUG-RESISTANT HIV-1 INFECTION
Authors:
- E.M. LaELE.M. La
- S.E. TalbirdSTS.E. Talbird
- A.J. BroganABA.J. Brogan
- A.E. DavisADA.E. Davis
- 1 May 2020
- journal article
- Published by Elsevier in Value in Health
- Vol. 23, S174